ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 092,11
-0,61%
Dow Jones
39 633,69
-0,60%
DAX
18 680,20
-0,25%
Brent Oil
81,585
-1,04%
Bitcoin
69 444,47
-0,99%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Obalon Therapeutics Inc (OBLN)

  7. Obalon Therapeutics Inc (OBLN) Actualités

OBLN

Obalon Therapeutics (OBLN)

Obalon Therapeutics Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:OBLN
DateHeureSourceTitreSymboleSociété
16/05/202312h02Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:OBLNObalon Therapeutics Inc
15/05/202323h07Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:OBLNObalon Therapeutics Inc
24/04/202315h07Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:OBLNObalon Therapeutics Inc
03/04/202323h12Edgar (US Regulatory)Notification That Annual Report Will Be Submitted Late (nt 10-k)NASDAQ:OBLNObalon Therapeutics Inc
17/03/202322h02Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:OBLNObalon Therapeutics Inc
14/02/202319h25Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:OBLNObalon Therapeutics Inc
08/02/202315h02Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(4) (424b4)NASDAQ:OBLNObalon Therapeutics Inc
03/02/202315h02Edgar (US Regulatory)Securities Registration Statement (s-1/a)NASDAQ:OBLNObalon Therapeutics Inc
03/02/202312h05Edgar (US Regulatory)Withdrawal of a Registration Statement Withdrawal Request (rw Wd)NASDAQ:OBLNObalon Therapeutics Inc
12/01/202323h10Edgar (US Regulatory)Securities Registration Statement (s-1)NASDAQ:OBLNObalon Therapeutics Inc
20/12/202222h36Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:OBLNObalon Therapeutics Inc
10/11/202222h56Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:OBLNObalon Therapeutics Inc
31/10/202221h03Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:OBLNObalon Therapeutics Inc
26/08/202222h22Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:OBLNObalon Therapeutics Inc
16/08/202212h03Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)NASDAQ:OBLNObalon Therapeutics Inc
22/03/202211h04Edgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:OBLNObalon Therapeutics Inc
21/09/202122h10Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:OBLNObalon Therapeutics Inc
03/09/202122h07Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:OBLNObalon Therapeutics Inc
21/05/202115h00Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:OBLNObalon Therapeutics Inc
12/05/202114h40GlobeNewswire Inc.Obalon Announces First Quarter 2021 Financial ResultsNASDAQ:OBLNObalon Therapeutics Inc
09/04/202123h22Edgar (US Regulatory)Registration Statement for Securities to Be Issued in Business Combination Transactions (s-4/a)NASDAQ:OBLNObalon Therapeutics Inc
30/03/202112h11Edgar (US Regulatory)Securities Registration: Business Combination (s-4)NASDAQ:OBLNObalon Therapeutics Inc
15/03/202115h51Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:OBLNObalon Therapeutics Inc
13/03/202101h12GlobeNewswire Inc.Obalon Announces Fourth Quarter and Full Year 2020 Financial ResultsNASDAQ:OBLNObalon Therapeutics Inc
03/02/202123h02Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:OBLNObalon Therapeutics Inc
06/11/202022h45GlobeNewswire Inc.Obalon Announces Third Quarter 2020 Financial ResultsNASDAQ:OBLNObalon Therapeutics Inc
25/09/202022h34Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:OBLNObalon Therapeutics Inc
01/09/202022h55Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:OBLNObalon Therapeutics Inc
13/08/202013h00GlobeNewswire Inc.Obalon Announces Consulting Agreement As Part of Strategy To Seek Coverage and Reimbursement for The Obalon Balloon SystemNASDAQ:OBLNObalon Therapeutics Inc
30/07/202012h38GlobeNewswire Inc.Obalon Announces Second Quarter 2020 Financial ResultsNASDAQ:OBLNObalon Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:OBLN

Dernières Valeurs Consultées

EU
AI
Air Liquide
NYSE
MRK
Merck
EU
SGO
Cie de SaintGobain
EU
DG
Vinci
SPI
SP500
S&P 500
NYSE
MCD
McDonalds
EU
CAP
Capgemini
NYSE
DIS
Walt Disney
COIN
ETHUSD
Ethereum
EU
ACA
Credit Agricole
EU
VIV
Vivendi
EU
PX4
SBF 120
EU
BN
Danone
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés